IREN – IREN Ltd

IREN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

18.01

Margin Of Safety %

Put/Call OI Ratio

0.69

EPS Next Q Diff

-0.6

EPS Last/This Y

-0.97

EPS This/Next Y

-0.6

Price

58.38

Target Price

78.85

Analyst Recom

1.88

Performance Q

45.89

Upside

-82.6%

Beta

4.19

Ticker: IREN

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-15	IREN	48.72	0.69	0.34	1850384
2026-04-16	IREN	47.82	0.70	0.51	1891447
2026-04-17	IREN	48.15	0.72	0.56	1945542
2026-04-20	IREN	48.62	0.72	0.42	1701381
2026-04-21	IREN	44.96	0.71	0.70	1784723
2026-04-22	IREN	48.37	0.73	0.42	1818807
2026-04-23	IREN	52.08	0.73	0.28	1874791
2026-04-24	IREN	51.04	0.71	0.61	1971935
2026-04-27	IREN	48.37	0.72	0.51	1798420
2026-04-28	IREN	44.89	0.73	0.43	1853273
2026-04-29	IREN	43.28	0.73	0.36	1922448
2026-04-30	IREN	45.33	0.73	0.76	1951729
2026-05-01	IREN	45.44	0.74	0.46	2023729
2026-05-04	IREN	49.14	0.71	0.42	1758533
2026-05-05	IREN	54.59	0.70	0.29	1834184
2026-05-06	IREN	61.21	0.70	0.34	1867055
2026-05-07	IREN	57.87	0.70	0.51	1973070
2026-05-08	IREN	61.24	0.71	0.51	2097907
2026-05-11	IREN	55.01	0.68	0.43	1930525
2026-05-12	IREN	56.5	0.69	0.35	2055986
2026-05-13	IREN	55.17	0.69	0.40	2126624
2026-05-14	IREN	58.13	0.69	0.51	2184008
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-15	IREN	48.84	-341.0	-497.7	-0.01
2026-04-16	IREN	47.68	-341.0	-494.2	-0.01
2026-04-17	IREN	48.10	-341.0	-496.3	-0.01
2026-04-20	IREN	48.71	-341.0	-496.5	-0.01
2026-04-21	IREN	45.16	-341.0	-491.0	-0.01
2026-04-22	IREN	48.37	-341.0	-500.3	-0.01
2026-04-23	IREN	52.02	-341.0	-500.5	-0.01
2026-04-24	IREN	50.62	-341.0	-494.0	-0.01
2026-04-27	IREN	48.38	-341.0	-492.9	-0.01
2026-04-28	IREN	44.45	-341.0	-490.5	-0.01
2026-04-29	IREN	42.89	-341.0	-493.5	-0.01
2026-04-30	IREN	45.48	-341.0	-499.5	-0.01
2026-05-01	IREN	45.63	-341.0	-495.9	-0.01
2026-05-04	IREN	49.47	-341.0	-501.0	-0.01
2026-05-05	IREN	54.74	-341.0	-502.5	-0.01
2026-05-06	IREN	60.99	-341.0	-503.0	-0.01
2026-05-07	IREN	56.72	-341.0	-491.2	-0.01
2026-05-08	IREN	61.19	-341.0	-500.8	-0.01
2026-05-11	IREN	55.16	-341.0	-489.3	-0.01
2026-05-12	IREN	56.55	-	623.1	-0.56
2026-05-13	IREN	55.15	-	586.0	-0.56
2026-05-14	IREN	58.38	-	647.3	-0.56
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-15	IREN	0.00	3.61	18.70
2026-04-17	IREN	0.00	3.61	18.70
2026-04-20	IREN	0.00	3.86	18.70
2026-04-21	IREN	0.00	3.86	18.70
2026-04-22	IREN	0.00	3.86	18.70
2026-04-23	IREN	0.00	3.86	18.70
2026-04-24	IREN	0.00	3.86	18.54
2026-04-27	IREN	0.00	2.94	19.62
2026-04-28	IREN	0.00	2.94	19.62
2026-04-29	IREN	0.00	2.94	19.62
2026-04-30	IREN	0.00	2.94	19.62
2026-05-01	IREN	0.00	2.94	19.62
2026-05-04	IREN	0.00	3.14	19.62
2026-05-05	IREN	0.00	3.14	19.62
2026-05-06	IREN	0.00	3.14	19.62
2026-05-07	IREN	0.00	3.14	19.62
2026-05-08	IREN	0.00	3.14	19.62
2026-05-11	IREN	0.00	1.79	19.62
2026-05-12	IREN	0.00	1.79	19.37
2026-05-13	IREN	0.00	1.79	18.01
2026-05-14	IREN	0.00	1.79	18.01
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.25

Avg. EPS Est. Current Quarter

-0.51

Avg. EPS Est. Next Quarter

-0.85

Insider Transactions

Institutional Transactions

1.79

Beta

4.19

Average Sales Estimate Current Quarter

196

Average Sales Estimate Next Quarter

407

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

78.85

P/E

201.1

Forward P/E

76.02

PEG

0.8

P/S

41.76

P/B

10.91

P/Free Cash Flow

EPS

0.29

Average EPS Est. Cur. Y

-0.56

EPS Next Y. (Est.)

-1.16

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

18.18

Relative Volume

1.48

Return on Equity vs Sector %

-5.9

Return on Equity vs Industry %

-8.5

EPS 1 7Days Diff

-0.9

EPS 1 30Days Diff

-0.93

EBIT Estimation

647.3

◆ IREN Financial

$58.40

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

6/25

Volume

0/15

Valuation

10/20

TP/AR

2/10

Options

5/10

RSI

60.8

Range 1M

67.2%

Sup Dist

8.6%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

20/25

Growth

12/30

Estimates

6/20

Inst/Vol

9/15

Options

7/10

EPS Yr

-235%

EPS NY

249.8%

52W%

72.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +35% upside

Quality

3/30

Valuation

10/30

Growth

9/25

Stability

4/10

LT Trend

4/5

Upside

+35%

Quality

IREN LIMITED

Sector: Financial Services

Industry: Capital Markets

Employees: 257

IREN Limited operates in the vertically integrated data center business in Australia and Canada. The company owns and operates computing hardware, as well as electrical infrastructure and data centers. It also mines Bitcoin, a scarce digital asset that is created and transmitted through the operation of a peer-to-peer network of computers running the Bitcoin software. The company was formerly known as Iris Energy Limited and changed its name to IREN Limited in November 2024. The company was incorporated in 2018 and is based in Sydney, Australia.

IREN

Latest News

—

Caricamento notizie per IREN…

stock quote shares IREN – IREN Ltd Stock Price stock today

news today IREN – IREN Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch IREN – IREN Ltd yahoo finance google finance

stock history IREN – IREN Ltd invest stock market

stock prices IREN premarket after hours

ticker IREN fair value insiders trading

IMRN – Immuron Limited ADR

IMRN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.6

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

0.64

EPS This/Next Y

Price

1.09

Target Price

Analyst Recom

Performance Q

57.8

Upside

-662.2%

Beta

0.83

Ticker: IMRN

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-15	IMRN	0.825	N/A	N/A	0
2026-04-20	IMRN	0.9576	N/A	N/A	0
2026-04-23	IMRN	0.8813	N/A	N/A	0
2026-04-24	IMRN	0.8935	N/A	N/A	0
2026-04-27	IMRN	0.8709	N/A	N/A	0
2026-04-28	IMRN	0.8241	N/A	N/A	0
2026-04-29	IMRN	0.8055	N/A	N/A	0
2026-04-30	IMRN	0.8455	N/A	N/A	0
2026-05-01	IMRN	0.8	N/A	N/A	0
2026-05-04	IMRN	0.8159	N/A	N/A	0
2026-05-05	IMRN	0.8195	N/A	N/A	0
2026-05-06	IMRN	0.8677	N/A	N/A	0
2026-05-07	IMRN	0.864	N/A	N/A	0
2026-05-08	IMRN	0.8495	N/A	N/A	0
2026-05-11	IMRN	0.86	N/A	N/A	0
2026-05-12	IMRN	0.83	N/A	N/A	0
2026-05-13	IMRN	0.9588	N/A	N/A	0
2026-05-14	IMRN	1.09	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-15	IMRN	0.85	-	-	-0.01
2026-04-16	IMRN	0.83	-	-	-0.01
2026-04-17	IMRN	0.97	-	-	-0.01
2026-04-20	IMRN	0.96	-	-	-0.01
2026-04-21	IMRN	0.96	-	-	-0.01
2026-04-22	IMRN	0.87	-	-	-0.01
2026-04-23	IMRN	0.88	-	-	-0.01
2026-04-24	IMRN	0.86	-	-	-0.01
2026-04-27	IMRN	0.84	-	-	-0.01
2026-04-28	IMRN	0.82	-	-	-0.01
2026-04-30	IMRN	0.83	-	-	-0.01
2026-05-01	IMRN	0.82	-	-	-0.01
2026-05-04	IMRN	0.84	-	-	-0.01
2026-05-05	IMRN	0.81	-	-	-0.01
2026-05-06	IMRN	0.85	-	-	-0.01
2026-05-07	IMRN	0.84	-	-	-0.01
2026-05-08	IMRN	0.82	-	-	-0.01
2026-05-11	IMRN	0.88	-	-	-0.01
2026-05-12	IMRN	0.84	-	-	-0.01
2026-05-13	IMRN	0.94	-	-	-0.01
2026-05-14	IMRN	1.09	-	-	-0.01
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-15	IMRN	0	2.03	0.17
2026-04-16	IMRN	0	2.03	0.17
2026-04-17	IMRN	0	2.03	0.17
2026-04-20	IMRN	0	1.83	0.17
2026-04-21	IMRN	0	1.83	0.17
2026-04-22	IMRN	0	1.83	0.17
2026-04-23	IMRN	0	1.83	0.17
2026-04-24	IMRN	0	1.83	0.17
2026-04-27	IMRN	0	1.92	0.36
2026-04-28	IMRN	0	1.92	0.36
2026-04-29	IMRN	0	1.92	0.36
2026-04-30	IMRN	0	1.92	0.36
2026-05-01	IMRN	0	1.92	0.36
2026-05-04	IMRN	0	1.85	0.36
2026-05-05	IMRN	0	1.85	0.36
2026-05-06	IMRN	0	1.85	0.36
2026-05-07	IMRN	0	1.85	0.36
2026-05-08	IMRN	0	1.85	0.36
2026-05-11	IMRN	0	1.86	0.36
2026-05-12	IMRN	0	1.86	0.60
2026-05-13	IMRN	0	1.86	0.60
2026-05-14	IMRN	0	1.86	0.60
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

1.86

Beta

0.83

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

81.7

Max Drawdown 5-Year %

-86.3

Target Price

P/E

Forward P/E

PEG

P/S

1.88

P/B

1.04

P/Free Cash Flow

EPS

-0.48

Average EPS Est. Cur. Y

-0.01

EPS Next Y. (Est.)

-0.02

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-61.85

Relative Volume

9.65

Return on Equity vs Sector %

-62.4

Return on Equity vs Industry %

-46.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ IMRN Healthcare

$1.11

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

14/20

Pullback

0/25

Volume

3/15

Valuation

12/20

TP/AR

1/10

Options

0/10

RSI

71.4

Range 1M

70.4%

Sup Dist

27.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

10/25

Growth

17/30

Estimates

2/20

Inst/Vol

9/15

Options

0/10

EPS Yr

98.6%

EPS NY

-26.9%

52W%

24.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +260.4% upside

Quality

6/30

Valuation

16/30

Growth

10/25

Stability

7/10

LT Trend

3/5

Upside

+260.4%

Quality

Immuron Limited

Sector: Healthcare

Industry: Biotechnology

Employees: 7

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. In additon, the company develops IMM-986, that is in pre-clinical stage. Further, it offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

IMRN

Latest News

—

Caricamento notizie per IMRN…

stock quote shares IMRN – Immuron Limited ADR Stock Price stock today

news today IMRN – Immuron Limited ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch IMRN – Immuron Limited ADR yahoo finance google finance

stock history IMRN – Immuron Limited ADR invest stock market

stock prices IMRN premarket after hours

ticker IMRN fair value insiders trading

IMMP – Immutep Limited ADR

IMMP — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.28

Margin Of Safety %

Put/Call OI Ratio

0.27

EPS Next Q Diff

EPS Last/This Y

0.05

EPS This/Next Y

0.03

Price

0.45

Target Price

4.35

Analyst Recom

2.67

Performance Q

-83.53

Upside

-2,977.8%

Beta

2.25

Ticker: IMMP

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-15	IMMP	0.5539	0.07	0.13	5125
2026-04-20	IMMP	0.6195	0.30	0.10	5154
2026-04-23	IMMP	0.5691	0.29	0.00	5404
2026-04-24	IMMP	0.5713	0.28	0.01	5483
2026-04-27	IMMP	0.5203	0.28	0.02	5468
2026-04-28	IMMP	0.4863	0.28	0.01	5482
2026-04-29	IMMP	0.476	0.27	0.00	5609
2026-04-30	IMMP	0.4654	0.27	0.14	5650
2026-05-01	IMMP	0.4358	0.27	0.05	5677
2026-05-04	IMMP	0.4614	0.27	0.00	5707
2026-05-05	IMMP	0.4627	0.27	0.00	5713
2026-05-06	IMMP	0.4444	0.27	6.00	5747
2026-05-07	IMMP	0.4352	0.27	1.83	5744
2026-05-08	IMMP	0.4461	0.26	0.00	5734
2026-05-11	IMMP	0.4448	0.26	18.67	5736
2026-05-12	IMMP	0.4712	0.27	3.42	5777
2026-05-13	IMMP	0.4649	0.27	0.76	5793
2026-05-14	IMMP	0.4522	0.27	0.12	5831
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-15	IMMP	0.55	-	57.6	-0.25
2026-04-16	IMMP	0.58	-	57.0	-0.25
2026-04-17	IMMP	0.58	-	56.6	-0.25
2026-04-20	IMMP	0.61	-	56.1	-0.25
2026-04-21	IMMP	0.59	-	56.5	-0.25
2026-04-22	IMMP	0.60	-	56.3	-0.25
2026-04-23	IMMP	0.57	-	56.8	-0.25
2026-04-24	IMMP	0.57	-	56.7	-0.25
2026-04-27	IMMP	0.52	-	57.6	-0.25
2026-04-28	IMMP	0.48	-	58.3	-0.25
2026-04-30	IMMP	0.46	-	58.6	-0.25
2026-05-01	IMMP	0.44	-	59.1	-0.25
2026-05-04	IMMP	0.46	-	59.0	-0.25
2026-05-05	IMMP	0.46	-	58.3	-0.25
2026-05-06	IMMP	0.44	-	58.6	-0.25
2026-05-07	IMMP	0.43	-	60.8	-0.25
2026-05-08	IMMP	0.45	-	60.6	-0.25
2026-05-11	IMMP	0.44	-	60.8	-0.25
2026-05-12	IMMP	0.47	-	60.3	-0.25
2026-05-13	IMMP	0.46	-	60.8	-0.25
2026-05-14	IMMP	0.45	-	61.3	-0.25
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-15	IMMP	0.00	39.38	0.89
2026-04-16	IMMP	0.00	39.38	0.89
2026-04-17	IMMP	0.00	39.38	0.89
2026-04-20	IMMP	0.00	140.51	0.89
2026-04-21	IMMP	0.00	140.51	0.89
2026-04-22	IMMP	0.00	140.51	0.89
2026-04-23	IMMP	0.00	140.51	0.89
2026-04-24	IMMP	0.00	140.51	0.89
2026-04-27	IMMP	0.00	100.10	0.85
2026-04-28	IMMP	0.00	100.10	0.85
2026-04-29	IMMP	0.00	100.10	0.85
2026-04-30	IMMP	0.00	100.10	0.85
2026-05-01	IMMP	0.00	100.10	0.85
2026-05-04	IMMP	0.00	78.59	0.85
2026-05-05	IMMP	0.00	78.59	0.85
2026-05-06	IMMP	0.00	78.59	0.85
2026-05-07	IMMP	0.00	78.59	0.85
2026-05-08	IMMP	0.00	78.59	0.85
2026-05-11	IMMP	0.00	76.61	0.85
2026-05-12	IMMP	0.00	76.61	4.28
2026-05-13	IMMP	0.00	76.61	4.28
2026-05-14	IMMP	0.00	76.61	4.28
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

76.61

Beta

2.25

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

91.7

Max Drawdown 5-Year %

-94.1

Target Price

4.35

P/E

Forward P/E

PEG

P/S

24.91

P/B

1.01

P/Free Cash Flow

EPS

-0.37

Average EPS Est. Cur. Y

-0.25

EPS Next Y. (Est.)

-0.22

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-2026.12

Relative Volume

0.03

Return on Equity vs Sector %

-111.8

Return on Equity vs Industry %

-96.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

0.01

EBIT Estimation

61.3

◆ IMMP Healthcare

$0.45

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

13/25

Volume

11/15

Valuation

12/20

TP/AR

0/10

Options

7/10

RSI

36.1

Range 1M

5.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

6/30

Estimates

0/20

Inst/Vol

5/15

Options

10/10

EPS Yr

-16.2%

EPS NY

45%

52W%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +866.7% upside

Quality

6/30

Valuation

16/30

Growth

6/25

Stability

7/10

LT Trend

3/5

Upside

+866.7%

Quality

Immutep Limited

Sector: Healthcare

Industry: Biotechnology

Employees:

Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.

IMMP

Latest News

—

Caricamento notizie per IMMP…

stock quote shares IMMP – Immutep Limited ADR Stock Price stock today

news today IMMP – Immutep Limited ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch IMMP – Immutep Limited ADR yahoo finance google finance

stock history IMMP – Immutep Limited ADR invest stock market

stock prices IMMP premarket after hours

ticker IMMP fair value insiders trading

GENE – Genetic Technologies Ltd. ADR

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=GENE #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

GENE — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.76

Target Price

6.87

Analyst Recom

Performance Q

-14.99

Upside

N/A

Beta

1.11

Ticker: GENE

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-15	GENE	0.765	N/A	N/A	0
2026-04-20	GENE	0.765	N/A	N/A	0
2026-04-23	GENE	0.765	N/A	N/A	0
2026-04-24	GENE	0.765	N/A	N/A	0
2026-04-27	GENE	0.765	N/A	N/A	0
2026-04-28	GENE	0.765	N/A	N/A	0
2026-04-29	GENE	0.765	N/A	N/A	0
2026-04-30	GENE	0.765	N/A	N/A	0
2026-05-01	GENE	0.765	N/A	N/A	0
2026-05-04	GENE	0.765	N/A	N/A	0
2026-05-05	GENE	0.765	N/A	N/A	0
2026-05-06	GENE	0.765	N/A	N/A	0
2026-05-07	GENE	0.765	N/A	N/A	0
2026-05-08	GENE	0.765	N/A	N/A	0
2026-05-11	GENE	0.765	N/A	N/A	0
2026-05-12	GENE	0.765	N/A	N/A	0
2026-05-13	GENE	0.765	N/A	N/A	0
2026-05-14	GENE	0.765	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=GENE 589 360 ]

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

1.11

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.5

Max Drawdown 5-Year %

-97.7

Target Price

6.87

P/E

Forward P/E

PEG

P/S

1.24

P/B

2.89

P/Free Cash Flow

EPS

-1.83

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-156.76

Relative Volume

Return on Equity vs Sector %

-680.2

Return on Equity vs Industry %

-667.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=GENE 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=GENE 589 450 ]

No data found for GENE

[News_GENE _Stock]

stock quote shares GENE – Genetic Technologies Ltd. ADR Stock Price stock today

news today GENE – Genetic Technologies Ltd. ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch GENE – Genetic Technologies Ltd. ADR yahoo finance google finance

stock history GENE – Genetic Technologies Ltd. ADR invest stock market

stock prices GENE premarket after hours

ticker GENE fair value insiders trading

WDS – Woodside Energy Group Ltd

WDS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.16

Margin Of Safety %

Put/Call OI Ratio

0.15

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

22.32

Target Price

23.92

Analyst Recom

2.69

Performance Q

21.18

Upside

-17.3%

Beta

0.34

Ticker: WDS

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-15	WDS	23.56	0.18	0.01	16817
2026-04-20	WDS	22.6	0.20	0.32	6215
2026-04-23	WDS	23.03	0.20	0.00	6791
2026-04-24	WDS	23.04	0.15	0.03	8782
2026-04-27	WDS	23.12	0.14	0.00	9014
2026-04-28	WDS	23.26	0.14	0.02	8965
2026-04-29	WDS	24.01	0.15	0.00	8934
2026-04-30	WDS	23.86	0.14	0.09	9058
2026-05-01	WDS	23.54	0.14	0.03	9144
2026-05-04	WDS	23.44	0.14	0.07	9230
2026-05-05	WDS	23.47	0.14	0.00	9262
2026-05-06	WDS	22.42	0.14	0.13	9326
2026-05-07	WDS	21.91	0.14	1.03	9413
2026-05-08	WDS	21.58	0.15	0.21	9624
2026-05-11	WDS	22.26	0.15	0.00	10584
2026-05-12	WDS	22.51	0.13	5.49	11571
2026-05-13	WDS	22.46	0.14	4.69	11701
2026-05-14	WDS	22.31	0.15	0.18	11855
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-15	WDS	23.56	-	-	-
2026-04-16	WDS	23.84	-	-	-
2026-04-17	WDS	22.40	-	-	-
2026-04-20	WDS	22.60	-	-	-
2026-04-21	WDS	22.74	-	-	-
2026-04-22	WDS	22.45	-	-	-
2026-04-23	WDS	23.03	-	-	-
2026-04-24	WDS	23.04	-	-	-
2026-04-27	WDS	23.12	-	-	-
2026-04-28	WDS	23.27	-	-	-
2026-04-30	WDS	23.87	-	-	-
2026-05-01	WDS	23.54	-	-	-
2026-05-04	WDS	23.44	-	-	-
2026-05-05	WDS	23.48	-	-	-
2026-05-06	WDS	22.41	-	-	-
2026-05-07	WDS	21.91	-	-	-
2026-05-08	WDS	21.59	-	-	-
2026-05-11	WDS	22.26	-	-	-
2026-05-12	WDS	22.51	-	-	-
2026-05-13	WDS	22.43	-	-	-
2026-05-14	WDS	22.32	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-15	WDS	0	0.61	0.15
2026-04-16	WDS	0	0.61	0.15
2026-04-17	WDS	0	0.61	0.15
2026-04-20	WDS	0	0.60	0.15
2026-04-21	WDS	0	0.60	0.15
2026-04-22	WDS	0	0.60	0.15
2026-04-23	WDS	0	0.60	0.15
2026-04-24	WDS	0	0.60	0.15
2026-04-27	WDS	0	0.52	0.15
2026-04-28	WDS	0	0.52	0.15
2026-04-29	WDS	0	0.52	0.15
2026-04-30	WDS	0	0.52	0.15
2026-05-01	WDS	0	0.52	0.15
2026-05-04	WDS	0	-0.02	0.15
2026-05-05	WDS	0	-0.02	0.15
2026-05-06	WDS	0	-0.02	0.15
2026-05-07	WDS	0	-0.02	0.15
2026-05-08	WDS	0	-0.02	0.15
2026-05-11	WDS	0	0.17	0.15
2026-05-12	WDS	0	0.17	0.16
2026-05-13	WDS	0	0.17	0.16
2026-05-14	WDS	0	0.17	0.16
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

0.17

Beta

0.34

Average Sales Estimate Current Quarter

3058

Average Sales Estimate Next Quarter

3151

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

17.1

Max Drawdown 5-Year %

-48.8

Target Price

23.92

P/E

15.69

Forward P/E

11.92

PEG

4.01

P/S

3.26

P/B

1.18

P/Free Cash Flow

EPS

1.42

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20.97

Relative Volume

0.45

Return on Equity vs Sector %

-2.7

Return on Equity vs Industry %

-5.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ WDS Energy

$22.31

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

15/25

Volume

11/15

Valuation

8/20

TP/AR

2/10

Options

7/10

RSI

44.3

Range 1M

36.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

6/30

Estimates

6/20

Inst/Vol

6/15

Options

10/10

EPS Yr

42.4%

EPS NY

-8%

52W%

76%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +68.8% upside

Quality

9/30

Valuation

14/30

Growth

7/25

Stability

4/10

LT Trend

0/5

Upside

+68.8%

Quality

Woodside Energy Group Limited

Sector: Energy

Industry: Oil & Gas E&P

Employees: 4693

Woodside Energy Group Ltd engages in the exploration, evaluation, development, production, marketing, and sale of hydrocarbons in the Asia Pacific, Africa, the Americas, and the Europe. It produces liquefied natural gas, pipeline gas, crude oil and condensate, and natural gas liquids. The company holds interests in the Pluto LNG, North West Shelf, Wheatstone and Julimar-Brunello, Bass Strait, Ngujima-Yin FPSO, Okha FPSO, Pyrenees FPSO, Macedon, Shenzi, Mad dog, Greater Angostura, as well as Scarborough, Sangomar, Trion, Calypso, Browse, Liard, Ruby, Sangomar, Atlantis, Woodside Solar opportunity, and Sunrise and Troubadour. It is also involved in the development of new energy products and lower-carbon services. The company was formerly known as Woodside Petroleum Ltd and changed its name to Woodside Energy Group Ltd in May 2022. Woodside Energy Group Ltd was founded in 1954 and is headquartered in Perth, Australia.

WDS

Latest News

—

Caricamento notizie per WDS…

stock quote shares WDS – Woodside Energy Group Ltd Stock Price stock today

news today WDS – Woodside Energy Group Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch WDS – Woodside Energy Group Ltd yahoo finance google finance

stock history WDS – Woodside Energy Group Ltd invest stock market

stock prices WDS premarket after hours

ticker WDS fair value insiders trading

BHP – BHP Group Limited

BHP — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.62

Margin Of Safety %

-12

Put/Call OI Ratio

0.69

EPS Next Q Diff

EPS Last/This Y

1.4

EPS This/Next Y

0.36

Price

88.97

Target Price

58.42

Analyst Recom

Performance Q

22.24

Upside

-41.1%

Beta

0.86

Ticker: BHP

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-15	BHP	79.87	0.76	0.90	145348
2026-04-16	BHP	79.47	0.76	0.48	145869
2026-04-17	BHP	80.43	0.76	0.41	146102
2026-04-20	BHP	79.6	0.77	0.66	129477
2026-04-21	BHP	77.69	0.77	2.30	129815
2026-04-22	BHP	80.56	0.78	0.20	130762
2026-04-23	BHP	79.86	0.77	0.69	131870
2026-04-24	BHP	79.84	0.77	0.61	132826
2026-04-27	BHP	79.86	0.77	0.83	133190
2026-04-28	BHP	78.15	0.78	0.12	136722
2026-04-29	BHP	77.06	0.74	0.77	140595
2026-04-30	BHP	79.31	0.74	0.06	140631
2026-05-01	BHP	79.05	0.70	0.08	146493
2026-05-04	BHP	77.89	0.67	0.16	150606
2026-05-05	BHP	79.23	0.67	1.48	151139
2026-05-06	BHP	84.34	0.69	0.68	154988
2026-05-07	BHP	82.51	0.69	0.77	155633
2026-05-08	BHP	84.74	0.69	1.01	156051
2026-05-11	BHP	87.65	0.70	0.32	156737
2026-05-12	BHP	88.36	0.69	0.75	160154
2026-05-13	BHP	90.8	0.69	0.48	162327
2026-05-14	BHP	88.94	0.69	0.16	165311
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-15	BHP	79.49	-	966.3	4.97
2026-04-16	BHP	79.46	-	873.2	4.97
2026-04-17	BHP	80.45	-	1067.7	4.97
2026-04-20	BHP	79.60	-	879.6	4.97
2026-04-21	BHP	77.69	-	517.3	4.97
2026-04-22	BHP	80.57	-	1273.3	4.97
2026-04-23	BHP	79.86	-	864.3	4.97
2026-04-24	BHP	79.82	-	903.3	4.88
2026-04-27	BHP	79.83	-	966.1	4.88
2026-04-28	BHP	78.14	-	423.6	4.89
2026-04-30	BHP	79.33	-	1449.0	4.89
2026-05-01	BHP	79.07	-	1896.8	4.89
2026-05-04	BHP	77.90	-	823.3	4.96
2026-05-05	BHP	79.24	-	2151.5	4.96
2026-05-06	BHP	84.35	-	3245.7	4.96
2026-05-07	BHP	82.53	-	2632.1	4.96
2026-05-08	BHP	84.72	-	992.0	4.96
2026-05-11	BHP	87.67	-	2098.4	4.96
2026-05-12	BHP	88.33	-	2038.8	4.96
2026-05-13	BHP	90.86	-	2085.5	4.96
2026-05-14	BHP	88.97	-	957.6	4.96
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-15	BHP	0	0.09	0.60
2026-04-16	BHP	0	0.09	0.60
2026-04-17	BHP	0	0.09	0.60
2026-04-20	BHP	0	-0.16	0.60
2026-04-21	BHP	0	-0.16	0.60
2026-04-22	BHP	0	-0.16	0.60
2026-04-23	BHP	0	-0.16	0.60
2026-04-24	BHP	0	-0.16	0.60
2026-04-27	BHP	0	-0.05	0.57
2026-04-28	BHP	0	-0.05	0.57
2026-04-29	BHP	0	-0.05	0.57
2026-04-30	BHP	0	-0.05	0.57
2026-05-01	BHP	0	-0.05	0.57
2026-05-04	BHP	0	-0.05	0.57
2026-05-05	BHP	0	-0.05	0.57
2026-05-06	BHP	0	-0.05	0.57
2026-05-07	BHP	0	-0.05	0.57
2026-05-08	BHP	0	-0.05	0.57
2026-05-11	BHP	0	0.08	0.57
2026-05-12	BHP	0	0.08	0.62
2026-05-13	BHP	0	0.08	0.62
2026-05-14	BHP	0	0.08	0.62
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

0.08

Beta

0.86

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

77.94

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

2.7

Max Drawdown 5-Year %

-37.2

Target Price

58.42

P/E

22.06

Forward P/E

17.79

PEG

2.72

P/S

4.18

P/B

4.48

P/Free Cash Flow

21.92

EPS

4.03

Average EPS Est. Cur. Y

4.96

EPS Next Y. (Est.)

5.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

18.97

Relative Volume

0.72

Return on Equity vs Sector %

Return on Equity vs Industry %

5.2

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

-0.04

EBIT Estimation

957.6

◆ BHP Basic Materials

$88.94

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

12/20

Pullback

0/25

Volume

6/15

Valuation

5/20

TP/AR

2/10

Options

4/10

RSI

68.2

Range 1M

83.8%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

15/25

Growth

13/30

Estimates

6/20

Inst/Vol

6/15

Options

5/10

EPS Yr

26.8%

EPS NY

-1.5%

52W%

94.9%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -21.7% upside

Quality

17/30

Valuation

1/30

Growth

11/25

Stability

5/10

LT Trend

4/5

Upside

-21.7%

Quality

MoS

-12%

BHP Group Limited

Sector: Basic Materials

Industry: Other Industrial Metals & Mining

Employees: 39369

BHP Group Limited operates as a resources company in Australia, Europe, China, Japan, India, South Korea, rest of Asia, North America, South America, and internationally. The company operates through Copper, Iron Ore, and Coal segments. It also engages in the mining of copper, uranium, gold, zinc, lead, molybdenum, silver, iron ore, cobalt, and metallurgical and energy coal. In addition, the company is involved in the mining, smelting, and refining of nickel, as well as potash development activities. Further, it provides towing, freight, marketing and trading, marketing support, finance, administrative, and other services. BHP Group Limited was founded in 1851 and is headquartered in Melbourne, Australia.

BHP

Latest News

—

Caricamento notizie per BHP…

stock quote shares BHP – BHP Group Limited Stock Price stock today

news today BHP – BHP Group Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch BHP – BHP Group Limited yahoo finance google finance

stock history BHP – BHP Group Limited invest stock market

stock prices BHP premarket after hours

ticker BHP fair value insiders trading

No more stocks to show

IREN – IREN Ltd

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IREN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

IMRN – Immuron Limited ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IMRN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y